Ultimately, the intricate loop involving WBP2 and the Hippo pathway provides multiple feedback mechanisms to boost the WBP2 level and inhibit Hippo signalling, resulting in a culminative equilibrium shift toward WBP2-driven cancer signalling (Figure 7B). This evidence concerns the gene WBP2 and cancer.